JAK2 and central nervous system cancer: A recent study indicated that the binding of T cells to glioma cells calls for the IFNγR signaling pathway (IFNGR1, JAK1 and JAK2) in which IFNGR1 was found necessary for this kind of cell-cell adhesion [53].